E-ISSN 2577-5669
 

Research Article 


Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T.

Abstract
Introduction: Cancer is an uncontrollable disease which destroys our body tissues rapidly and it is the most leading cause of death all over the world. Cassia oleoresin is an Indian traditional plant which is commonly used as a spice. It is used to prevent many diseases without causing any side effects. It has proven to have anticancer activity against liver cancer cell lines. The present study was designed to evaluate the anticancer activity of Cassia oleoresin against liver cancer cell lines.
Materials and methods: Cassia oleoresin (product number 4010000195) was obtained from Synthite Valley Private Limited. MTT assay was used to check the cell viability against liver cancer cell line which was treated with increasing concentration of Cassia oleoresin extract for 24 hours. The result was interpreted using SPSS software correlated using One Way ANOVA.
Results: Increase in the concentration of the Cassia oleoresin extract shows decrease in the percentage of cell viability which proves the significant anticancer activity. The cell viability was 20% at 200 μg/ml concentration of extract. The IC50 value was 65 μg/ml.
Conclusion: The extract of cassia oleoresin demonstrated potent anticancer activity against liver cancer cell lines. Hence, it can be used for treating liver cancer after evaluating the practical applicability and clinical efficacy of the drug.

Key words: Cassia oleoresin, Liver cancer cell line, Anticancer activity, Cell viability, new approach


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by P. HARINI
Articles by ANITHA ROY
Articles by S. RAGHUNANDHAKUMAR
Articles by P. ELUMALAI
Articles by LAKSHMI T
on Google
on Google Scholar


REFERENCES
1. ICD-10 Ruhsal ve DavraniĢsal Bozukluklar Siniflandirilmasi. Klinik Tanimlamalar ve Tani Kila vuzu. Özturk M, Ulug B (Çev.), Ankara, Turkiye Sinir ve Ruh Sagligi Dernegi, 1994.
2. Breuer J, Freud S. Studies on hysteria. J Strachey, A Strachey (Eds.), The Standard Edition of the Complete Psychological Works of Sigmund Freud, Vol. II, London, Hogarth Press and the Institute of Psycho-Analysis, 1955, p.1-311.
3. Özturk O. Nevrotik, stresle ilgili ve somatoform bozukluklar. Ruh Sagligi ve Bozukluklari, 11. baski, Ankara: Tuna Matbaacilik, 2008, s.512-537.
4. Ludwig AM. Hysteria: A neurobiological theory. Arch Gen Psychiatry 1972; 27(Suppl.6):771-777.
5. Harvey S, Stanton BR, David AS. Conversion disorder: towards a neurobiological understanding. Neuropsychiatric Disease and Treatment 2006; 2(Suppl.1):13-20.
6. Black DN, Seritan AL, Taber KH, Hurley RA. Conversion hysteria: lessons from functional imaging. J Neuropsychiatry Clin Neurosci 2004; 16:245-251. [DOI via Crossref]    [Pubmed]   
7. Cureoglu S, Altindag A, Osma Ü, Özen ġ, Oktay F, Meriç F, ve ark. Konversiyonlu hastalarda beyin sapi uyarilmiĢ iĢitme potansiyellerinin degerlendirilmesi. Klinik Psikofarmokoloji Bulteni 2000; 10:129-132.
8. Zhou G, Cox LC. Vestibular evoked myogenic potentials: history and overview. American Journal of Audiology 2004; 13(Suppl.2):135-143.
9. Uyaroglu FG. Klik Uyaranla OluĢturulan Vestibuler Myojenik Potansiyellerin (K-VEMP) Dogasi ve Klinik Uygulamalardaki Yeri. YayimlanmamiĢ Uzmanlik Tezi, Ġzmir, Ege Üniversitesi, 2009.
10. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV), Washington DC, American Psychiatric Press, 1997.
11. Hamilton M. Development of a rating scale for primary depressive illness. Br J Sdc Clin Psychol 1967; 6:278-296. [DOI via Crossref]   
12. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55. [DOI via Crossref]    [Pubmed]   
13. Akkuzu HG. Bening paroksismal pozisyonel vertigo ve Meniere Hastaliginda uyarilmiĢ vestibuler myojenik potansiyeller. Uzmanlik Tezi, Ankara, BaĢkent Üniversitesi, 2003.
14. Welgampola MS, Colebatch JG. Characteristics and clinical applications of vestibular-evoked myogenic potentials. Neurology 2005; 64:1682-1688. [DOI via Crossref]    [Pubmed]   
15. Colebatch JG, Halmagyi GM, Skuse NF. Myogenic potentials generated by a click-evoked vestibulocolic reflex. Journal of Neurology, Neurosurgery, and Psychiatry 1994; 57:190-197. [DOI via Crossref]   
16. Murofushi T, Matsuzaki M, Chih-Hsiu W. Shorttone burst-evoked myogenic potentials on the sternocleidomastoid muscle: are these potentials also of vestibular origin? Arch Otolaryngol Head Neck Surg 1999; 125:660-664.
17. Gurses N, Temuçin ÇM, Ergun EL, Ertugrul A, Özer S, Demir B. Konversiyon bozuklugunda uyarilmiĢ potansiyeller ve beyin kan akimi degi-Ģiklikleri: olgu sunumu ve gozden geçirme. Turk Psikiyatri Dergisi 2008; 19(Suppl.1):101-107.
18. Yazici KM, Demirci M, Demir B, Ertugrul A. Abnormal somatosensory evoked potentials in two patients with conversiyon disorders. Psychi atry and Clinical Neurosciences 2004; 58:222-225. [DOI via Crossref]   
19. Dogan O. Konversiyon bozuklugu. E Koroglu, C Guleç (Ed.), Psikiyatri Temel Kitabi, ikinci baski, Ankara: HYB, 2007, s.377-385.
20. Kose S, Tunca Z, Çakmur R, Ġdiman F, Fidaner C. Konversiyon bozukluklarinda olaya bagli iĢitsel uyarilmiĢ potansiyeller (P300): Depresyon ve Anksiyete ile ĠliĢkileri. Turk Psikiyatri Dergisi 1998; 9:1-11.
21. Liepert J, Hassa T, Tuscher O, Schmidt R. Electrophysiological correlates of motor conversion disorder. Mov Disord 2008; 23(Suppl.15):2171-2176.
22. Lutkenhoner B, Basel T. Deconvolution of the vestibular evoked myogenic potential. Journal of Theoretical Biology 2012; 294:87-97. [DOI via Crossref]    [Pubmed]   

How to Cite this Article
Pubmed Style

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T. Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines. J Complement Med Res. 2021; 12(4): 24-29. doi:10.5455/jcmr.2021.12.04.04


Web Style

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T. Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines. https://www.jocmr.com/?mno=35955 [Access: August 07, 2022]. doi:10.5455/jcmr.2021.12.04.04


AMA (American Medical Association) Style

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T. Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines. J Complement Med Res. 2021; 12(4): 24-29. doi:10.5455/jcmr.2021.12.04.04



Vancouver/ICMJE Style

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T. Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines. J Complement Med Res. (2021), [cited August 07, 2022]; 12(4): 24-29. doi:10.5455/jcmr.2021.12.04.04



Harvard Style

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T (2021) Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines. J Complement Med Res, 12 (4), 24-29. doi:10.5455/jcmr.2021.12.04.04



Turabian Style

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T. 2021. Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines. Journal of Complementary Medicine Research, 12 (4), 24-29. doi:10.5455/jcmr.2021.12.04.04



Chicago Style

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T. "Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines." Journal of Complementary Medicine Research 12 (2021), 24-29. doi:10.5455/jcmr.2021.12.04.04



MLA (The Modern Language Association) Style

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T. "Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines." Journal of Complementary Medicine Research 12.4 (2021), 24-29. Print. doi:10.5455/jcmr.2021.12.04.04



APA (American Psychological Association) Style

P. HARINI, ANITHA ROY, S. RAGHUNANDHAKUMAR, P. ELUMALAI, LAKSHMI T (2021) Anti Cancer Activity of Cassia Oleoresin Against Liver Cancer Cell Lines. Journal of Complementary Medicine Research, 12 (4), 24-29. doi:10.5455/jcmr.2021.12.04.04